Clinical Trials Browser

Adenocarcinoma, Prostatic Neoplasms

NCT07507916 2026-04-02

Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2 Not yet recruiting

32 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT07489820 2026-03-24

AAPICO

Phase NA Not yet recruiting

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06834204 2026-03-23

ACCESS-PC

Phase NA Not yet recruiting

266 enrolled

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

MIDAS-SBRT

Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

AAPICO

ACCESS-PC

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

PRIAPUS-PCa

Endeavor-2

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Lutécio

TA-P-OLIM

CONVERT-HB1

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NACRE-2

PROSTIA- BP

PCS-XII

URO-ROBOT-2023

Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer

TRACE

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer